BioCentury
ARTICLE | Clinical News

Cenderitide: Phase I ongoing

October 24, 2011 7:00 AM UTC

Nile completed dosing in a placebo-controlled, U.S. Phase I trial in 58 patients evaluating subcutaneous cenderitide. Patients received 2 bolus injections of cenderitide, or 2 fixed dose levels or a w...